Recurrent acute myeloid leukemia Clinical Trials

Delta Trials indexes 100 clinical trials for Recurrent acute myeloid leukemia in its publicly accessible dataset. Of these, 32 enrolling participants at this time and 23 trials have reached completion. This research takes place spanning 82 research sites around the world. An additional 45 trials are in preparatory or other active non-recruiting stages. Since 2020, 19 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.